title: Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
abstract: OBJECTIVE
  The present study examined three kinds of subjective assessment scales in the same patient group with schizophrenia to analyze the correlations among scores obtained in relation to the background data.
  
  
  METHODS
  Thirty-six patients with schizophrenia were examined with the 26-item short form of the World Health Organization Quality of Life (WHO-QOL 26), Subjective Well-being under Neuroleptic drug treatment: Short Japanese version (SWNS) and Self-Efficacy for Community Life scale (SECL) for subjective assessment scales, five kinds of neurocognitive tests, Positive and Negative Syndrome Scale (PANSS) for clinical symptom, Social Functioning Scale (SFS), and Global Assessment of Functioning (GAF) scale for social functioning.
  
  
  RESULTS
  The scores for delusions (components of positive syndrome), anxiety and depression (components of general psychopathology) on the PANSS significantly correlated with QoL and subjective well-being scores. In contrast, the scores for components of negative syndrome were not correlated with the subjective assessment scores. Furthermore, none of the clinical symptom scores were correlated with the score in self-efficacy scale. The SFS and GAF scores were significantly correlated with the subjective assessment scores. There were significant correlations among the scores on the three subjective assessment scales.
  
  
  CONCLUSIONS
  Each scale has different features and should be utilized depending upon the expected effect of treatment or the purpose of assessment. The treatments provided to patients must be directed at improving both psychological and social impairments, in order to enhance the social functioning and QoL of patients.
authors.affiliation: Department of Neuropsychiatry, Ginza Taimei Clinic, Tokyo, Japan. gi026037@hotmail.com
authors.forename: Bun
authors.initials: B
authors.lastname: Chino
authors.forename: Takahiro
authors.initials: T
authors.lastname: Nemoto
authors.forename: Chiyo
authors.initials: C
authors.lastname: Fujii
authors.forename: Masafumi
authors.initials: M
authors.lastname: Mizuno
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001294:Attitude to Health; D003072:Cognition Disorders / Q000175:diagnosis; D005260:Female; D006304:Health Status; D006801:Humans; D008297:Male; D009483:Neuropsychological Tests; D010549:Personal Satisfaction; D010555:Personality Inventory; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data*; D011788:Quality of Life / Q000523:psychology; D012559:Schizophrenia / Q000175:diagnosis* / Q000188:drug therapy; D012565:Schizophrenic Psychology; D020377:Self Efficacy; D012917:Social Adjustment; D011795:Surveys and Questionnaires
chemical_list: D014150:Antipsychotic Agents